Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 19, 2012 - Issue 2
966
Views
44
CrossRef citations to date
0
Altmetric
Original Article

18F-FDG PET/CT in patients with amyloid light-chain amyloidosis: case-series and literature review

, , , , , , , , , & show all
Pages 94-98 | Received 11 Jan 2012, Accepted 01 Mar 2012, Published online: 16 May 2012

References

  • Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos Trans R Soc Lond, B, Biol Sci 2001;356:203–10; discussion 210.
  • Hawkins PN. Serum amyloid P component scintigraphy for diagnosis and monitoring amyloidosis. Curr Opin Nephrol Hypertens 2002;11:649–655.
  • Bartel TB, Haessler J, Brown TL, Shaughnessy JD Jr, van Rhee F, Anaissie E, Alpe T, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009;114:2068–2076.
  • Kung J, Zhuang H, Yu JQ, Duarte PS, Alavi A. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography. Clin Nucl Med 2003;28:975–976.
  • Ollenberger GP, Knight S, Tauro AJ. False-positive FDG positron emission tomography in pulmonary amyloidosis. Clin Nucl Med 2004;29:657–658.
  • Currie GP, Rossiter C, Dempsey OJ, Legge JS. Pulmonary amyloid and PET scanning. Respir Med 2005;99:1463–1464.
  • Grubstein A, Shitrit D, Sapir EE, Cohen M, Kramer MR. Pulmonary amyloidosis: detection with PET-CT. Clin Nucl Med 2005;30:420–421.
  • Yadav S, Sharma S, Gilfillan I. Unusual positron emission tomography findings in pulmonary amyloidosis: a case report. J Cardiothorac Surg 2006;1:32.
  • Yoshida A, Borkar S, Singh B, Ghossein RA, Schöder H. Incidental detection of concurrent extramedullary plasmacytoma and amyloidoma of the nasopharynx on [18F]fluorodeoxyglucose positron emission tomography/computed tomography. J Clin Oncol 2008; 26:5817–5819.
  • Seo JH, Lee SW, Ahn BC, Lee J. Pulmonary amyloidosis mimicking multiple metastatic lesions on F-18 FDG PET/CT. Lung Cancer 2010;67:376–379.
  • Costantino F, Loeuille D, Dintinger H, Péré P, Chary-Valckenaere I. Fixed digital contractures revealing light-chain amyloidosis. Joint Bone Spine 2009;76:553–555.
  • Tan H, Guan Y, Zhao J, Lin X. Findings of pulmonary amyloidosis on dual phase FDG PET/CT imaging. Clin Nucl Med 2010;35:206–207.
  • Mainenti PP, Segreto S, Mancini M, Rispo A, Cozzolino I, Masone S, Rinaldi CR, et al. Intestinal amyloidosis: two cases with different patterns of clinical and imaging presentation. World J Gastroenterol 2010;16:2566–2570.
  • Mekinian A, Ghrenassia E, Pop G, Roberts S, Prendki V, Stirnemann J, Weinmann P, Fain O. Visualization of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT scan. Clin Nucl Med 2011;36:52–53.
  • Soussan M, Ouvrier MJ, Pop G, Galas JL, Neuman A, Weinmann P. Tracheobronchial FDG uptake in primary amyloidosis detected by PET/CT. Clin Nucl Med 2011;36:723–724.
  • Son YM, Choi JY, Bak CH, Cheon M, Kim YE, Lee KH, Kim BT. 18F-FDG PET/CT in primary AL hepatic amyloidosis associated with multiple myeloma. Korean J Radiol 2011;12:634–637.
  • Gertz M, Comenzo R, Falk R, Fermand JP. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis: a consensus opinion from 10th international symposium on amyloid and amyloidosis. Am J Haematol 2005;79:319–328.
  • Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR Am J Roentgenol 2008;190:W151–W156.
  • Langah R, Spicer K, Gebregziabher M, Gordon L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J Nucl Cardiol 2009;16:801–810.
  • Rabinovici GD, Furst AJ, O’Neil JP, Racine CA, Mormino EC, Baker SL, Chetty S, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007; 68:1205–1212.
  • Wall JS, Kennel SJ, Stuckey AC, Long MJ, Townsend DW, Smith GT, Wells KJ, et al. Radioimmunodetection of amyloid deposits in patients with AL amyloidosis. Blood 2010;116:2241–2244.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.